Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-17 4:12 pm Purchase | 2025-06-12 | 13G | Larimar Therapeutics, Inc. LRMR | Millennium Management LLC | 3,563,602 5.600% | 3,563,602 (New Position) | Filing History |
| 2025-05-14 12:25 pm Sale | 2025-03-31 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 5,571,963 9.100% | -871,323 (-13.52%) | Filing History |
| 2025-05-13 11:33 am Sale | 2025-03-31 | 13G | Larimar Therapeutics, Inc. LRMR | GOLDMAN SACHS GROUP INC GS | 2,600,211 4.100% | -1,891,806 (-42.11%) | Filing History |
| 2025-04-22 2:28 pm Sale | 2025-03-31 | 13G | Larimar Therapeutics, Inc. LRMR | BlackRock Inc. BLK | 3,079,665 4.800% | -186,240 (-5.70%) | Filing History |
| 2025-04-16 5:11 pm Purchase | 2025-04-09 | 13G | Larimar Therapeutics, Inc. LRMR | Opaleye Management Inc. | 3,952,409 6.170% | 2,392,409 (+153.36%) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | BlackRock Inc. BLK | 3,265,905 5.100% | 3,265,905 (New Position) | Filing History |
| 2025-01-08 11:49 am Purchase | 2024-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 6,443,286 10.100% | 876,431 (+15.74%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR | Blue Owl Capital Holdings LP | 4,166,829 6.530% | 752,361 (+22.03%) | Filing History |
| 2024-11-14 11:41 am Purchase | 2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 5,566,855 8.700% | 2,925,790 (+110.78%) | Filing History |
| 2024-11-14 09:16 am Sale | 2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR | Verition Fund Management LLC | 594,067 0.900% | -2,217,064 (-78.87%) | Filing History |
| 2024-11-06 2:29 pm Purchase | 2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR | GOLDMAN SACHS GROUP INC GS | 4,492,017 7.000% | 4,492,017 (New Position) | Filing History |
| 2024-03-15 4:37 pm Purchase | 2024-03-14 | 13D | Larimar Therapeutics, Inc. LRMR | James E. Flynn | 21,273,474 33.320% | 8,300 (+0.04%) | Filing History |
| 2024-02-26 4:17 pm Purchase | 2024-02-16 | 13G | Larimar Therapeutics, Inc. LRMR | RA Capital Management, L.P. | 6,045,351 9.500% | 6,045,351 (New Position) | Filing History |
| 2024-02-16 2:11 pm Purchase | 2024-02-16 | 13D | Larimar Therapeutics, Inc. LRMR | James E. Flynn | 21,265,174 34.820% | 4,291,539 (+25.28%) | Filing History |
| 2024-02-15 5:20 pm Unchanged | 2024-02-13 | 13D | Larimar Therapeutics, Inc. LRMR | James E. Flynn | 16,973,635 39.200% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:57 pm Purchase | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Blue Owl Capital Holdings LP | 3,414,468 7.780% | 3,414,468 (New Position) | Filing History |
| 2024-02-14 4:46 pm Sale | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Perceptive Advisors LLC | 0 0.000% | -2,860,000 (Position Closed) | Filing History |
| 2024-02-14 08:55 am Purchase | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Verition Fund Management LLC | 2,811,131 6.400% | 2,811,131 (New Position) | Filing History |
| 2024-02-13 5:31 pm Purchase | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 2,641,065 6.000% | 2,641,065 (New Position) | Filing History |
| 2023-08-18 2:45 pm Purchase | 2023-08-10 | 13G | Larimar Therapeutics, Inc. LRMR | JANUS HENDERSON GROUP PLC JHG | 2,191,411 5.100% | 2,191,411 (New Position) | Filing History |